3 Biotech Stocks You Should Know About

Biotech ETF XBI has outperformed lately, but its top holdings are a different story

Patrick Martin

Managing Editor

Jul 17, 2024 at 2:35 PM

In June, we profiled biotech exchange-traded fund (ETF) SPDR S&P Biotech ETF (XBI) amid a historically bullish month. XBI proceeded to rattle off a 4% win for June and is up 7.3% in July already. Where do the ETF's top holdings stand?

The shares of EXACT Sciences Corporation (NASDAQ:EXAS) are down 1.1% to trade at $49.14 today. Despite bouncing 21% off its June 25 annual lows of $40.62, the cancer diagnostics stock is 33.5% lower in 2024.

Sarepta Therapeutics Inc (NASDAQ:SRPT) stock is 1.8% lower to trade at $146.16 at last check. The shares have taken a 15.5% haircut off their June 21 annual high of $173.25, but remain up 51.6% year-to-date.

United Therapeutics Corp. (NASDAQ:UTHR) stock is a powerhouse, hitting a record high of $339.56 today after a price-target hike from Leerink to $344 from $338. Up 1.6% at $333.44 at last glance, UTHR has tacked on 51.6% in 2024.

Follow @Schaeffers

Two High-Octane Trade Ideas. One Simple Goal: Intraday Profits.

Dynamite Day Trading Signals delivers two same-day options trades every week — powered by proprietary intraday analysis and 43+ years of trading expertise.

But this isn’t just another stream of alerts.

It’s a structured plan with clear entry and exit points – designed for traders who want to act fast, trade smart, and wrap up gains before the closing bell.

No guesswork. No overnight exposure – Just two well-researched setups per week — whether you prefer buying premium or selling it.

And the results speak for themselves: subscribers have locked in +245.8% total profit over the last six months (since inception!).

👉 Start your one-month trial now for just $10, and be ready for the next trade alert.